Sarepta Therapeutics Stock Performance
as on October 9, 2026 at 6:59 am IST
Day's Low
Day's High
$17.23$18.27
5.49%
Downside
0.22%
Upside
52 Week's Low
52 Week's High
$14.68$25.3219.47%
Downside
38.89%
Upside
Sarepta Therapeutics share price movements today
- Previous Close
- $17.50
- Open
- $17.27
- Volume
- 1.6M
- Market Cap
- $1.8B
- Day's Low - High
- $17.23 - $18.27
- 52 Week Low - High
- $14.68 - $25.32
Sarepta Therapeutics Historical Returns
- 1 Month Return
- -23.07 %
- 3 Month Return
- -12.53 %
- 1 Year Return
- -25.13 %
- 3 Year Return
- -86.03 %
- 5 Year Return
- -81.78 %
Sarepta Therapeutics Stock Fundamentals & Key Indicators
Check Sarepta Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.8B
EPS (TTM)
-1.44
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
26.64%
PE Ratio (TTM)
-12.15
Industry PE ratio
-6.36
PEG Ratio
0.01
EBITDA
-14.6M
Revenue (TTM)
2.0B
Profit Margin
58.56%
Return On Equity TTM
-9.96%
Sarepta Therapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Sarepta Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| Neutral | $1.8B | -81.78% | -12.15 | 58.56% | 0.00% | |
| Neutral | $74.8B | -35.56% | -23.49 | -12.57% | 0.00% | |
| StrongBuy | $127.3B | 182.58% | 29.00 | 86.04% | 0.00% | |
| Buy | $74.8B | 34.93% | 17.64 | 84.86% | 0.50% |
Stock Returns calculator for Sarepta Therapeutics Stock including INR - Dollar returns
The Sarepta Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Sarepta Therapeutics investment value today
Current value as on today
₹85,974
Returns
Returns from Sarepta Therapeutics Stock
Dollar Impact
₹7,125 (+7.12%)
Analyst Recommendation on Sarepta Therapeutics Stock
Based on 12 analysts
16.67%
Buy
50.00%
Hold
33.33%
Sell
Based on 12 analysts, 50% of analysts recommend a 'HOLD' rating for Sarepta Therapeutics. Average target price of $21.73
Sarepta Therapeutics Share Price Target
Get share price movements and forecasts by analysts on Sarepta Therapeutics.
What analysts predicted
16.11%UPSIDE
Target Price
$21.73
Current Price
$18.23
Analyzed by
12 Analysts
High
$38
Target
$21.73
Low
$5
Sarepta Therapeutics target price $21.73, a slight upside of 16.11% compared to current price of $18.23. According to 12 analysts rating.
Indian Investors' Interest in Sarepta Therapeutics Stock
Search interest for Sarepta Therapeutics Stock has decreased by -15% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Sarepta Therapeutics Quarterly Profit & Loss
All numbers in Millions USD
Sarepta Therapeutics Annual Profit & Loss
All numbers in Millions USD
Sarepta Therapeutics Quarterly Cash Flow
All numbers in Millions USD
Sarepta Therapeutics Annual Cash Flow
All numbers in Millions USD
Sarepta Therapeutics News & Key Events
Today's Timeline - 08 September
Tue, 06:30 PM
-Sarepta announces 25 recipients of Route 79 scholarships for individuals affected by Duchenne.
Tue, 10:01 PM
-H.C. Wainwright reiterates Sell rating on Sarepta after Novartis trial failure, lowering price target to $5.
Tue, 10:32 PM
-Sarepta shares fell over 9% after Novartis' treatment failure raised concerns about similar therapies.
Today's Timeline - 08 September
Tue, 10:40 PM
-Mizuho believes Sarepta's selloff is overdone, maintains Outperform rating with a $31 price target.
Tue, 11:25 PM
-Jefferies maintains Buy rating on Sarepta, citing potential for SRP-1003 despite Novartis trial results.
Insights on Sarepta Therapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers
In the last 1 year, Moderna, Inc. Common Stock has given 603.7% return, outperforming this stock by 628.8%
- NO EFFECT
Against Peers
In the last 3 years, Moderna, Inc. Common Stock has given 89.1% return, outperforming this stock by 175.0%
NEGATIVE IMPACTRevenue Fall
Revenue is down for the last 2 quarters, 730.80M → 401.25M (in $), with an average decrease of 45.1% per quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 330.95M → -4.88M (in $), with an average decrease of 101.5% per quarter
- NEGATIVE IMPACT
Price Dip
In the last 3 years, SRPT stock has moved down by -85.9%
About Sarepta Therapeutics
| Organisation | Sarepta Therapeutics |
| Headquarters | 215 First Street, Cambridge, MA, 02142, US |
| Industry | Biotechnology |
| CEO | Michael E. Severino |
Key Management of Sarepta Therapeutics
Name | Title |
|---|---|
Mr. Ian Michael Estepan | President & COO |
Dr. Louise R. Rodino-Klapac Ph.D. | President of Research & Development and Technical Operations |
Dr. Michael E. Severino M.D. | CEO & Director |
Tamara Thornton | Director of Finance, Treasury & Investor Relations |
Ms. Alison Nasisi | Executive VP & Chief People Officer |
Dr. Diane L. Berry Ph.D. | Executive VP and Chief of Global Policy & Advocacy Officer |
Mr. Ryan H. Wong | Executive VP & CFO |
Ms. Cristin L. Rothfuss J.D. | Executive VP, General Counsel & Company Secretary |
Mr. Douglas S. Ingram Esq., J.D. | Advisor |
Rachael Potter Ph.D. | Chief Scientific Officer |
FAQs
What is Sarepta Therapeutics share price today?
Sarepta Therapeutics share price today is $18.23 as on at the close of the market. Sarepta Therapeutics share today touched a day high of $18.27 and a low of $17.23.
What is the 52 week high and 52 week low for Sarepta Therapeutics share?
Sarepta Therapeutics share touched a 52 week high of $25.32 on and a 52 week low of $14.68 on . Sarepta Therapeutics stock price today i.e. is closed at $18.23,which is 28.00% down from its 52 week high and 24.18% up from its 52 week low.
What is Sarepta Therapeutics's market capitalisation today?
Sarepta Therapeutics market capitalisation is $0.00T as on .
How to invest in Sarepta Therapeutics Stock (SRPT) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Sarepta Therapeutics on INDmoney app. Click on Buy button.
What is the minimum amount required to buy Sarepta Therapeutics Stock (SRPT) from India?
Indian investors can start investing in Sarepta Therapeutics (SRPT) shares with as little as ₹96.779998779297 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹967.80 in Sarepta Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Sarepta Therapeutics share’s latest price of $18.23 as on October 9, 2026 at 1:29 am IST, you will get 0.5485 shares of Sarepta Therapeutics. Learn more about
fractional shares .
What are the returns that Sarepta Therapeutics has given to Indian investors in the last 5 years?
Sarepta Therapeutics stock has given -81.78% share price returns and 28.18% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?